Search filters

List of works by Wafaa El-Akel

Accurate Prediction of Advanced Liver Fibrosis Using the Decision Tree Learning Algorithm in Chronic Hepatitis C Egyptian Patients.

scientific article published on 6 January 2016

Assessment of hepatic fibrosis in pediatric cases with hepatitis C virus in Egypt.

scientific article

Changes in liver stiffness measurements and fibrosis scores following sofosbuvir based treatment regimens without interferon.

scientific article published on 8 February 2017

Circulating microRNA, miR-122 and miR-221 signature in Egyptian patients with chronic hepatitis C related hepatocellular carcinoma.

scientific article published on November 2014

Clinical, biochemical and pathological profiles of 5464 Egyptian chronic hepatitis C-infected patients

scientific article

Coinfection with hepatitis C virus and schistosomiasis: fibrosis and treatment response.

scientific article published on May 2013

Comparison of Machine Learning Approaches for Prediction of Advanced Liver Fibrosis in Chronic Hepatitis C Patients.

scientific article published on 4 April 2017

Efficacy and safety of sofosbuvir-based therapy in hepatitis C virus recurrence post living donor liver transplant: A real life egyptian experience

scientific article published on 14 December 2018

Epstein-Barr virus and Interleukin-28B polymorphism in the prediction of response to interferon therapy in hepatitis C patients.

scientific article published on 30 October 2015

Estrogen-related MxA transcriptional variation in hepatitis C virus-infected patients ⬇️

scientific article published on September 3, 2011

Evaluation of accuracy of elastography point quantification versus other noninvasive modalities in staging of fibrosis in chronic hepatitis C virus patients

scientific article published on 01 August 2018

Evaluation of acoustic radiation force impulse (ARFI) elastography as non-invasive diagnostic tool in living donor liver transplantation

scientific article published on 01 February 2019

Fibroscan of chronic HCV patients coinfected with schistosomiasis.

scientific article published on 27 August 2013

Generic daclatasvir plus sofosbuvir, with or without ribavirin, in treatment of chronic hepatitis C: real-world results from 18 378 patients in Egypt.

scientific article

Hepatic fibrosis and serum alpha-fetoprotein (AFP) as predictors of response to HCV treatment and factors associated with serum AFP normalisation after treatment

scientific article published on September 2013

Hepatitis C genotype 4 with normal transaminases: Correlation with fibrosis and response to treatment, a cohort Egyptian study of 4277 patients ⬇️

scientific article published on March 26, 2013

High SVR rate following retreatment of non-sustained virological responders to sofosbuvir based anti-HCV therapies regardless of RAS testing: A real-life multicenter study

scientific article published on 23 June 2019

IP-10 Serum Level in Chronic Hepatitis C Virus Patients: Relation to Fibrosis and Response to Combined Interferon/Ribavirin Therapy.

scientific article published on 14 May 2015

Impact of old Schistosomiasis infection on the use of transient elastography (Fibroscan) for staging of fibrosis in chronic HCV patients.

scientific article

Improvement of steatosis after interferon therapy in HCV genotype 4 is related to weight loss.

scientific article published on March 2009

Liver fibrosis staging through a stepwise analysis of non-invasive markers (FibroSteps) in patients with chronic hepatitis C infection

scientific article published on 20 March 2013

Liver stiffness measurements and FIB-4 are predictors of response to sofosbuvir-based treatment regimens in 7256 chronic HCV patients

scientific article published on 16 August 2019

NS5A sequence heterogeneity of hepatitis C virus genotype 4a predicts clinical outcome of pegylated-interferon-ribavirin therapy in Egyptian patients

scientific article

National treatment programme of hepatitis C in Egypt: Hepatitis C virus model of care

scientific article

Non-invasive prediction of hepatic fibrosis in patients with chronic HCV based on the routine pre-treatment workup.

scientific article published on November 2012

Planning and prioritizing direct acting antivirals treatment for HCV patients in countries with limited resources: lessons from the Egyptian experience.

scientific article published on 6 December 2017

Real life Egyptian experience of efficacy and safety of Simeprevir/Sofosbuvir therapy in 6211 chronic HCV genotype IV infected patients

scientific article

Relation of ALT and AST levels to the histopathological changes in liver biopsies of patients with chronic hepatitis C genotype 4.

scientific article published on 13 July 2015

Response to Real life Egyptian experience of efficacy / safety of Simeprevir\ Sofosbuvir in HCV genotype IV.

scientific article

Risk factors for hepatitis C virus acquisition and predictors of persistence among Egyptian children ⬇️

scientific article published on September 15, 2011

Serious Adverse Events with Sofosbuvir Combined with Interferon and Ribavirin: Real-Life Egyptian Experience.

scientific article

Serum autoantibodies positivity prevalence in patients with chronic HCV and impact on pegylated interferon and ribavirin treatment response ⬇️

scientific article published on June 14, 2013

Single nucleotide polymorphism at exon 7 splice acceptor site of OAS1 gene determines response of hepatitis C virus patients to interferon therapy.

scientific article

Sofosbuvir-based treatment regimens: real life results of 14 409 chronic HCV genotype 4 patients in Egypt.

scientific article

Spur-of-the-Moment Modification in National Treatment Policies Leads to a Surprising HCV Viral Suppression in All Treated Patients: Real-Life Egyptian Experience

scientific article published on 22 January 2018

Study of predictive value of pediatric risk of mortality (PRISM) score in children with end stage liver disease and fulminant hepatic failure.

scientific article published on 20 October 2010

Sustained virologic response and changes in liver fibrosis parameters following 12-wk administration of generic sofosbuvir and daclatasvir in HIV/HCV-coinfected patients with HCV genotype 4 infection

scientific article published on 01 April 2020

The Effect of Peginterferon Alpha-2a vs. Peginterferon Alpha-2b in Treatment of Naive Chronic HCV Genotype-4 Patients: A Single Centre Egyptian Study ⬇️

scientific article published on May 28, 2013

The adverse effects of interferon-free regimens in 149 816 chronic hepatitis C treated Egyptian patients.

scientific article

The assessment of data mining for the prediction of therapeutic outcome in 3719 Egyptian patients with chronic hepatitis C.

scientific article

The impact of interleukin 28b gene polymorphism on the virological response to combined pegylated interferon and ribavirin therapy in chronic HCV genotype 4 infected egyptian patients using data mining analysis ⬇️

scientific article

Therapeutic outcome of 6198 interferon-naïve Egyptian patients with chronic hepatitis C: a real-life experience and lessons to be learned in DAAs' era.

scientific article

Transcriptional response of MxA, PKR and SOCS3 to interferon-based therapy in HCV genotype 4-infected patients and contribution of p53 to host antiviral response.

scientific article published on 20 May 2011

Ultrasonography as a non-invasive tool for detection of nonalcoholic fatty liver disease in overweight/obese Egyptian children.

scientific article

Paulina is supported by:

About Paulina

Help